Zealand Pharma issues almost USD 40m in shares

The firm’s issuance and private placement represent 6.6% of its currently registered share capital, and will bring in an expected total of DKK 275m (USD 39.4m).
Photo: Zealand Pharma / PR
Photo: Zealand Pharma / PR
by marketwire, translated by daniel pedersen

Biotech firm Zealand Pharma has announced a directed issuance of 2.89 million new shares and a private placement, corresponding to a total 6.6% of the firm’s share capital.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading